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1048Objective: Impaired angiogenesis is a known consequence of metabolic syndrome (MetS); however, the
mechanism is not fully understood. Recent studies have shown that the notch signaling pathway is an integral
component of cardiac angiogenesis. We tested, in a clinically relevant swine model, the effects of MetS on notch
and apoptosis signaling in chronically ischemic myocardium.
Methods: Ossabaw swine were fed either a regular diet (control [CTL], n ¼ 8) or a high-cholesterol diet
(MetS, n ¼ 8) to induce MetS. An ameroid constrictor was placed to induce chronic myocardial ischemia.
Eleven weeks later, the wine underwent cardiac harvest of the ischemic myocardium.
Results: Downregulation of pro-angiogenesis proteins notch2, notch4, jagged2, angiopoietin 1, and endothelial
nitric oxide synthase were found in the MetS group compared with the CTL group. Also, upregulation of
pro-apoptosis protein caspase 8 and downregulation of anti-angiogenesis protein phosphorylated forkhead
box transcription factor 03 and pro-survival proteins phosphorylated P38 and heat shock protein 90 were present
in the MetS group. Cell death was increased in the MetS group compared with the CTL group. Both CTL and
MetS groups had a similar arteriolar count and capillary density, and notch3 and jagged1 were both similarly
concentrated in the smooth muscle wall.
Conclusions: MetS in chronic myocardial ischemia significantly impairs notch signaling by downregulating
notch receptors, ligands, and pro-angiogenesis proteins. MetS also increases apoptosis signaling, decreases
survival signaling, and increases cell death in chronically ischemic myocardium. Although short-term
angiogenesis appears unaffected in this model of early MetS, the molecular signals for angiogenesis are
impaired, suggesting that inhibition of notch signaling might underlie the decreased angiogenesis in later stages
of MetS. (J Thorac Cardiovasc Surg 2014;148:1048-55)The metabolic syndrome (MetS) is a cluster of metabolic
derangements that includes obesity, insulin resistance,
glucose intolerance, dyslipidemia, and hypertension.
MetS substantially increases the risk of cardiovascular dis-
ease and mortality.1,2 Despite advancements in surgical
technique and percutaneous interventions, patients with
hypertension, hyperlipidemia, and diabetes have had
significantly greater mortality after angioplasty, coronary
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The Journal of Thoracic and Cardiovascular Surpromising results from animal studies in therapeutic
revascularization with growth factor, gene, or cell therapy
have met with disappointing results in humans, with minimal
clinical improvements in myocardial angiogenesis.4 Not sur-
prisingly, young healthy animals with chronic myocardial
ischemia are better able to adapt to the ischemic insult, but
older patients with multiple comorbidities, including MetS,
have limited myocardial adaptability to ischemia. The
discordant results between positive findings from animal
studies and negative clinical results highlights the need to un-
derstand the effects of MetS on the molecular angiogenic
signaling pathways using a clinically relevant animal model.
Ossabaw miniswine are a breed of feral pigs that were iso-
lated on Ossabaw Island off the coast of Georgia almost 500
years ago by Spanish explorers. This pig breed has been iden-
tified as an excellent model for MetS owing to its ‘‘thrifty ge-
notype,’’ which allowed these pigs to adapt to the harsh island
conditions by storing large amounts of fat during the feasting
period.5 When sedentary and fed a high-fat, high-calorie,
atherogenic diet, these swine develop profound obesity and
all the hallmark features of MetS and are, thus, a useful
model to study MetS and coronary artery disease.5-7
We recently demonstrated that animals with chronic
myocardial ischemia and perivascular vascular endothelial
growth factor (VEGF) had significantly improvedgery c September 2014
Abbreviations and Acronyms
Ang1 ¼ angiopoietin 1
DLL ¼ delta like ligand
eNOS ¼ endothelial nitric oxide synthase
MetS ¼ metabolic syndrome
NIH ¼ National Institutes of Health
SMA ¼ smooth muscle actin
TUNEL ¼ terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate-biotin
nick end labeling
VEGF ¼ vascular endothelial growth factor
VEGFR ¼ VEGF receptor
Elmadhun et al Evolving Technology/Basic Scienceneovascularization and Notch receptor and ligand expres-
sion.8 The Notch signaling pathway is an evolutionarily
conserved pathway important for many processes,
including cell fate determination differentiation, prolifera-
tion, apoptosis, and regeneration.9 Studies have shown
that postnatal Notch signaling is critical for angiogen-
esis.10,11 Interest is growing in the clinical utility of Notch
modulators to suppress angiogenesis in tumors and
promote angiogenesis in ischemic myocardium.12 Although
research in the role of Notch signaling in developmental
biology is longstanding, the role of Notch signaling in
mature myocardium in response to ischemia and MetS is
largely unknown. The purpose of the present study was to
examine the effects of MetS on Notch signaling in response
to chronic myocardial ischemia in the clinically relevant
Ossabaw model of early MetS.E
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SMETHODS
Animal Model
Sixteen intact male Ossabaw miniswine (Purdue Ossabaw Facility,
Indiana University, Indianapolis, Ind) were split into 2 groups according
to diet at 6 weeks of age. The control (CTL) group was fed 500 g/d of
regular chow (n ¼ 8). The high-cholesterol swine were fed 500 g/d of
high-cholesterol chow (MetS group, n ¼ 8) consisting (by weight)
of 4% cholesterol, 17.2% coconut oil, 2.3% corn oil, 1.5% sodium
cholate, and 75% regular chow (Sinclair Research, Columbia, Mo). After
9 weeks of diet initiation, all the swine underwent surgical placement of an
ameroid constrictor to induce chronic myocardial ischemia (see ‘‘Surgical
Interventions’’). Postoperatively, all the swine continued their respective
diets. Eleven weeks after ameroid constrictor placement, all the swine
underwent euthanasia and cardiac tissue harvest. All the swine were
observed to ensure complete consumption of food and unlimited access
to water and were housed in a warm nonstressful environment for the
duration of the experiment.
Surgical Interventions
Anesthesia. Anesthesiawas inducedwith an intramuscular injection of
telazol (4.4 mg/kg). The swine were endotracheally intubated and
mechanically ventilated at 12 to 20 breaths/min. General anesthesia was
maintained with a gas mixture of oxygen at 1.5 to 2 L/min and 0.75% to
3.0% isoflurane.The Journal of Thoracic and CarAmeroid constrictor placement. For ameroid constrictor
placement, the swine were given a single dose of intravenous enrofloxacin
(5 mg/kg) for antibiotic prophylaxis, and general anesthesia was induced
and maintained. The swine were prepared and draped in the usual sterile
fashion. The heart was exposed through a left minithoracotomy through
the fourth intercostal space and pericardiotomy. The left atrial appendage
was retracted, and the left circumflex artery was dissected at the take
off of the left main coronary artery. A titanium ameroid constrictor
(1.75-2.25 mm internal diameter) ameroid constrictor was placed around
the proximal left circumflex artery, just after its take off from the left
main coronary artery (Research Instruments SW, Escondito, Calif).
The pericardium was loosely reapproximated with interrupted 4-0 Nurolon
sutures (Ethicon, Somerville, NJ), followed by a layered closure of the
surgical incision. Postoperative pain was controlled by a single dose of
intramuscular buprenorphine (0.03 mg/kg) and a 72-hour fentanyl patch
(4 mg/kg). All the swine received 325 mg of aspirin daily starting 1 day
preoperatively and continuing for 5 days for prophylaxis against
thromboembolic events. All the swine continued perioperative antibiotics
(enrofloxacin 68 mg orally daily for 5 days).
Cardiac harvest. For cardiac harvest, with the swine under general
anesthesia, the heart was exposed by way of a median sternotomy, and
the swine were euthanized by exsanguination. Cardiac tissue from the
ischemic territory in the left circumflex artery distribution was collected
for additional analysis. The institutional animal care and use committee
of the Rhode Island Hospital approved all experiments. The swine were
cared for in compliance with the ‘‘Principles of Laboratory Animal
Care’’ formulated by the National Society for Medical Research and the
‘‘Guide for the Care and Use of Laboratory Animals’’ (National Institutes
of Health [NIH] publication no. 5377-3, 1996).Immunohistochemical Staining for Angiogenesis
For immunohistochemical staining for angiogenesis, frozen
myocardium was sectioned (10-mm thickness) and fixed in 10% formalin
for 10 minutes. The sections were blocked with 1% bovine serum albumin
in phosphate-buffered saline for 1 hour at room temperature and
incubated with antibodies against the porcine endothelial marker CD31
(R&D Systems, Minneapolis, Minn) and smooth muscle actin (SMA)
(Sigma-Aldrich, St Louis, Mo), followed by the appropriate Alexa-Fluor
conjugated antibody (Jackson ImmunoResearch, West Grove, Pa) for 45
minutes. Slides were then mounted with 460-diamidino-2-phenylindole-2
HCl–containing medium (Vectashield; Vector Laboratories, Burlingame,
Calif). Images were captured at 320 magnification with a Nikon E800
Eclipse microscope (Nikon, Tokyo, Japan) at the same exposure in 3
random fields. The capillaries were defined as structures 5 to 25 mm2 in
cross-sectional area, and arterioles were defined by co-localization of
SMA (red) and CD31 (green) staining. The arteriolar and capillary
density were measured using Image J software (NIH, Bethesda, Md).
The percentage of capillary and arteriolar density for each pig was
averaged from the 3 randomly selected myocardial tissue sections.Protein Expression
To determine protein expression, 40 mg of the radioimmuno-
precipitation assay (Boston BioProducts, Ashland, Mass) soluble fraction
of myocardial lysates was fractionated using sodium dodecyl sulfate
polyacrylamide gel electrophoresis 3% to 8% Tris-acetate gel (NuPage
Novex Mini Gel; Invitrogen, Carlsbad, Calif) for molecular weight targets
>100 kDa and 4% to 12% Bis-Tris gels for molecular weight targets
<100 kDa (NuPage Novex Mini Gel; Invitrogen). The protein was then
transferred to polyvinylidene difluoride membranes (Millipore, Billerica,
Mass) and incubated overnight at 4C with primary antibodies at the
dilutions recommended by the manufacturer against Notch1, Notch2,
Notch3, Notch4, Jagged1, Jagged2, VEGF receptor (VEGFR)2,
vascular endothelial cadherin, endothelial nitric oxide synthase (eNOS),diovascular Surgery c Volume 148, Number 3 1049
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Stransforming growth factor-b, caspase 8, caspase 3, cleaved caspase 3,
forkhead box transcription factor 03 (Fox03), phosphorylated Fox03,
apoptosis inducing factor, P38, phosphorylated P38, heat shock protein
90 (all from Cell Signaling, Danvers, Mass) and VEGFR3 and angiopoietin
1 (Ang1; both from Abcam, Cambridge, Mass). The membranes were
incubated with the appropriate horseradish peroxidase-linked secondary
antibody for 1 hour at room temperature (Jackson ImmunoResearch,
West Grove, Pa). Immune complexes were visualized with enhanced
chemiluminescense, and the images were captured with a digital
camera system (G-Box; Syngene, Cambridge, United Kingdom). Band
densitometry was quantified as arbitrary light units using Image-J software
(NIH). All membranes were probed with glyceraldehyde-3-phosphate
dehydrogenase (Cell Signaling) to correct for loading error.
Immunohistochemical Staining for Notch Signaling
Proteins
For immunohistochemical staining for Notch signaling proteins, frozen
myocardium was sectioned (10-mm thickness) and fixed in 10% formalin
for 10 minutes. The sections were blocked with 1% bovine serum albumin
in phosphate-buffered saline for 1 hour at room temperature and
incubated with antibodies against Notch2, Notch3, Notch4, or Jagged1
(Cell Signaling) and SMA (Sigma-Aldrich) co-staining, followed by the
appropriate Alexa-Fluor conjugated antibody (Jackson ImmunoResearch)
for 45 minutes. The slides were then mounted with Vectashield
(Vector Laboratories). The images were captured at 320 magnification
with a Nikon E800 Eclipse microscope (Nikon) at the same exposure in
3 random fields. The immunofluorescence mean intensity was measured
using ImageJ software (NIH). The immunofluorescence mean intensity
for each pig was averaged from the 3 randomly selected myocardial tissue
sections.
Terminal Deoxynucleotidyl Transferase-Mediated
Deoxyuridine Triphosphate-Biotin Nick End
Labeling Staining
For terminal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate-biotin nick end labeling (TUNEL) staining, frozen
myocardium from the ischemic territory was sectioned (10-mm thickness).
Apoptotic cells were identified using the commercially available ApopTag
detection kit (Millipore), according to the manufacturer’s instructions.
The images were captured at 320 magnification using Aperio ScanScope
technology (Leica Biosystems, Vista, Calif) in 3 random fields from each
pig. The percentage of TUNEL-positive cardiomyocytes per high powered
field was measured using ImageJ software (NIH). The percentage of cell
death per high powered field for each pig was averaged from the 3
randomly selected myocardial tissue sections.
Statistical Analysis
All results are reported as the mean  standard error of the mean.
Student’s t test was used to compare the mean values using GraphPad
Prism, version 5.0, Software (GraphPad Software, Inc, San Diego, Calif).
Protein expression is reported as the fold change compared with the
CTL group.
RESULTS
Animal Model
All the swine included in the present analysis survived
the entire experiment. One pig in the CTL group died on
postoperative day 8, and 1 in the MetS group died on
postoperative day 2. The necropsy findings were
unremarkable, and we assumed that both pigs had died of
an acute ventricular arrhythmia. The pigs that did not1050 The Journal of Thoracic and Cardiovascular Sursurvive to completion of the experiment were excluded
from analysis and replaced with new animals. We have pre-
viously reported that no difference was seen in myocardial
perfusion or contractility.13We also reported that the pigs in
the study group developed key components of MetS,
including obesity (body mass index 31.9 vs 35.1 kg/m2
for CTL vs MetS, respectively; P < .01), hypertension
(mean arterial pressure, 85 vs 112 mm Hg for CTL vs
MetS, respectively; P ¼ .02), dyslipidemia (67.9 vs 343
mg/dL total cholesterol for CTL vs MetS, respectively;
P< .01), and glucose intolerance in response to dextrose
infusion (44, 149, and 82 mg/dL blood glucose in the
CTL group vs 60, 214, and 130 mg/dL in the MetS group
at 0, 30, and 60 minutes, respectively, after dextrose
infusion; P<.01).13
Vessel Density in Chronically Ischemic Myocardium
No difference was seen in the capillary density in the
chronically ischemic myocardium as measured by immuno-
histochemical staining for CD31 (9.53%  0.72% and
10.78%  0.74% area/high power field for CTL and
MetS, respectively; P ¼ .28). Also, no difference was
seen in the arteriolar count as measured by immunohisto-
chemical co-staining of CD31 and SMA (22.91  1.18
and 23.73  0.93 count/high power field for CTL and
MetS, respectively; P ¼ .59; Figure 1).
Angiogenesis Protein Expression in Chronically
Ischemic Myocardium
We analyzed the myocardial lysates of the chronically
ischemic myocardium for expression of all 4 mammalian
Notch receptors (Notch1-4) and 2 Notch ligands (Jagged1
and 2). In the MetS group, a decrease was seen in the
expression of Notch2, Notch4, and Jagged2 compared
with that in the CTL group. Also, decreased expression of
pro-angiogenesis proteins Ang1 and eNOS was seen in
the MetS group compared with the CTL group. No
difference was found in the expression of Notch1, Notch3,
Jagged 1, VEGFR1, VEGFR2, and transforming growth
factor-b in the CTL and MetS groups (Table 1).
Notch Receptor and Ligand Staining in Chronically
Ischemic Myocardium
We performed immunohistochemical staining of
transmural sections of the ischemic myocardium to
determine the histologic location of the Notch2, Notch3,
and Notch4 receptors by co-staining with SMA. SMA stains
vascular smooth muscle, which is located in the wall of the
arteries and arterioles. Notch receptors Notch2, Notch3, and
Notch4 and Notch ligand Jagged1 (green) were highly
concentrated in the smooth muscle wall and co-localized
with SMA (red; Figures 2 and 3). Although no difference
was seen in overall Notch3 intensity in the CTL and MetS
groups, a significant decrease was seen in Notch2 andgery c September 2014
FIGURE 1. Vessel density in chronically ischemic myocardium. Left, Arrows indicate capillaries; right, arrows indicate arterioles. CTL, Ossabaw control
group; MetS, Ossabaw atherogenic diet (to induce metabolic syndrome) group; HPF, high-powered field.
Elmadhun et al Evolving Technology/Basic ScienceNotch4 intensity in the MetS group compared with the CTL
group. A trend was seen toward decreased Jagged1
immunofluorescence in the MetS group compared with
the CTL group, but the difference did not reach statistical
significance.Apoptosis and Survival Protein Expression in
Chronically Ischemic Myocardium
We analyzed the myocardial lysates of the chronically
ischemic myocardium for the expression of apoptosis and
survival signaling proteins.We found that in theMetS group,
upregulation of pro-apoptosis protein caspase 8 and down-
regulation of the inhibited form of pro-apoptosis protein
Fox03, phosphorylated Fox03, were present compared
with the CTL group. Also, significant downregulation ofTABLE 1. Angiogenesis protein expression in chronically ischemic
myocardium
Variable CTL group MetS group P value
Notch1 1.0  0.132 0.81  0.053 .20
Notch2 1.0  0.105 0.64  0.096 .03
Notch3 1.0  0.076 1.11  0.088 .38
Notch4 1.0  0.128 0.66  0.050 .02
Jagged1 1.0  0.143 1.17  0.151 .43
Jagged2 1.0  0.050 0.79  0.083 .05
VEGFR2 1.0  0.082 1.12  0.127 .43
VEGFR3 1.0  0.100 1.05  0.107 .76
VE cadherin 1.0  0.052 0.82  0.113 .18
Ang1 1.0  0.070 0.72  0.045 .01
eNOS 1.0  0.038 0.51  0.126 .003
TGF-b 1.0  0.037 0.98  0.070 .77
Data presented as fold change  standard error of the mean compared with the CTL
group. CTL, Control; MetS, Ossabaw atherogenic diet (to induce metabolic
syndrome); VEGFR, vascular endothelial growth factor receptor; VE, vascular
endothelial; Ang1, angiopoietin 1; eNOS, endothelial nitric oxide synthase;
TGF, transforming growth factor.
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Sthe pro-survival proteins phosphorylated P38 and heat shock
protein 90 was present in theMetS group compared with the
CTL group. Also, increased expression of pro-apoptosis
proteins cleaved caspase 3 and apoptosis inducing factor
was seen in the MetS group, but the difference did not reach
statistical significance (P ¼ .06 and P ¼ .09, respectively)
compared with the CTL group (Table 2). No difference
was found in the expression of pro-apoptosis proteins
caspase 3 and Fox03 or pro-survival protein P38.
TUNEL Staining in Chronically Ischemic
Myocardium
We sampled the chronically ischemic myocardium and
performed TUNEL staining to quantify the cell death in
the CTL and MetS groups. We found a significant increase
in cardiomyocyte cell death in the MetS group compared
with the CTL group (2.73  0.36 vs 1.71  0.34,
respectively; P ¼ .05; Figure 4).
DISCUSSION
Coronary collateralization in response to chronic
myocardial ischemia is an important endogenous
mechanism to preserve myocardial function, limit infarct
size, and improve long-term survival. It is therefore critical
to understand the molecular basis for how the MetS
inhibits coronary collateralization and angiogenesis. In
this clinically relevant swine model of chronic myocardial
ischemia, we found that early MetS attenuated Notch,
angiogenesis, and survival signaling and upregulated
apoptosis signaling in chronically ischemic myocardium.
Previously, we had demonstrated that feeding Ossabaw
swine a high-fat, high-calorie, atherogenic diet resulted in
all the hallmark components of MetS, including obesity,
insulin resistance, glucose intolerance, elevated blood
pressure, and hyperlipidemia.13,14diovascular Surgery c Volume 148, Number 3 1051
FIGURE 2. Notch receptor and ligand staining in chronically ischemic myocardium. Top, Notch3 (green) and smooth muscle actin (SMA; red). Bottom,
Notch ligand jagged1 (green). CTL, Ossabaw control group; MetS, Ossabaw atherogenic diet (to induce metabolic syndrome) group.
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SThe Notch signaling pathway is a short-range communi-
cation system between 2 physically adjacent cells, so-called
juxtacrine signaling. Mammals have 4 Notch receptors,
Notch 1 to 4, and 5 ligand receptors, delta like ligand
(DLL)1, 3, and 4 and Jagged1 and 2. The vascular
endothelium only expresses the receptors Notch1, Notch2,FIGURE 3. Notch receptor staining in chronically ischemic myocardium. Top,
(SMA). CTL, Ossabaw control group; MetS, Ossabaw atherogenic diet (to indu
1052 The Journal of Thoracic and Cardiovascular Surand Notch4 and the ligands Jagged1, Jagged2, DLL1, and
DLL4.12 Notch3 is predominantly expressed in the adult
arterial smooth muscle wall.15 Notch signaling is an integral
part of both angiogenesis and vasculogenesis and is
required for arterial and venous blood vessel differentia-
tion.16 The Notch pathway also maintains endothelialNotch2 (green); bottom, Notch4 (green). Red indicates smooth muscle actin
ce metabolic syndrome) group.
gery c September 2014
TABLE 2. Apoptosis and survival protein expression in chronically
ischemic myocardium
Variable CTL MetS P value
Caspase 8 1.0  0.051 1.19  0.051 .02
Caspase 3 1.0  0.065 1.04  0.093 .72
Cleaved caspase 3 1.0  0.162 1.55  0.210 .06
Fox03 1.0  0.025 0.95  0.033 .27
pFox03 (Ser253) 1.0  0.039 0.84  0.040 .01
AIF 1.0  0.108 1.32  0.136 .09
P38 1.0  0.028 1.03  0.053 .61
pP38 (Thr180/Tyr182) 1.0  0.052 0.80  0.029 .01
HSP90 1.0  0.038 0.85  0.052 .04
Data presented as fold change  standard error of the mean compared with the CTL
group. CTL, Control; MetS, Ossabaw atherogenic diet (to induce metabolic
syndrome); Fox03, forkhead box transcription factor 03; pFox03, phosphorylated
Fox03;AIF, apoptosis inducing factor; pP38, phosphorylated P39;HSP90, heat shock
protein 90.
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Shomeostasis by modulating new blood vessel sprouting by
way of DLL4/Notch1; protecting endothelial cells from
tumor necrosis factor-a–mediated apoptosis by way of
Notch4; and regulating bone marrow endothelial progenitor
cell proliferation, apoptosis, and migration to ischemic
tissue by way of Notch1.12
The Notch pathway has been proposed as a possible
target for therapeutic angiogenesis and cardioprotection;
however, studies in a large animal model with clinically
relevant comorbidities, such as MetS, are lacking.12 In the
present study, we have demonstrated that MetS has an
inhibitory effect on Notch signaling. We found that Notch
receptors Notch2, Notch3, and Notch4 and Notch ligand
Jagged1 were primarily concentrated in the vascular smooth
muscle wall and co-localized with SMA. This was an
expected result given that Notch3 is expressed in vascular
smooth muscle cells. We also found decreased Notch2
and Notch2 staining and a trend toward decreased Jagged1
tissue staining in the MetS group compared with the CTL
group, suggesting that decreased Notch signaling occurs
in the vascular smooth muscle wall in animals with MetS.
Jagged1 has been identified as an important Notch target
during arterial wall assembly, with Jagged1 inhibition
resulting in arterial defects and impaired vascular smoothFIGURE 4. Terminal deoxynucleotidyl transferase-mediated deoxyuridine trip
myocardium. Brown spots (arrow) in nuclei indicate cell death.CTL, Control gro
HPF, high-powered field.
The Journal of Thoracic and Carmuscle differentiation.17 Our results suggest that perhaps
MetS inhibits the Notch signaling angiogenic response to
chronic myocardial ischemia. We have also reported that
downregulation occurred of pro-angiogenic proteins
eNOS and Ang1. Previous studies have demonstrated a
direct link between Notch signaling and eNOS activity.18,19
Notch activation activates eNOS, which induces nitric
oxide synthesis. In an animal model of hind limb
ischemia, Notch inhibition in endothelial cells reduced
reperfusion and nitric oxide generation.18 Ang1 is an
angiogenic factor that also activates the pro-survival
signaling pathway and initiates stem cell homing in the
setting of myocardial ischemia.20 In a porcine model of
myocardial infarction, co-expression of VEGF and
Ang1 was shown to increase angiogenesis, myocardial
perfusion, and cardiomyocyte proliferation in ischemic
myocardium.21 In the present study, MetS had an inhibitory
effect on the normal angiogenic response to ischemia by
downregulating eNOS and Ang1.
It was somewhat surprising that in this model of early
MetS in Ossabaw swine, we did not observe a reduction
in collateral-dependent myocardial perfusion, which we
have reported using other strains of pigs.22,23 This might
be specific to the Ossabaw pigs and in part a result of
increased vascular relaxation observed using these pigs in
early-stage MetS.13 Perhaps the increased microvascular
relaxation results from upregulation of the peroxisome
proliferator-activated receptor pathway. It could also be
related to the ‘‘thrifty genotype,’’ which enabled this pig
breed to survive in the feast and famine ecology on Ossabaw
Island, despite their predilection to obesity and coronary
artery disease. It could also be that this transient
improvement in microvessel reactivity we had previously
reported also occurs in humans in the presence of early
MetS. Later stage MetS in Ossabaw swine, in contrast,
has been associated with decreased endothelium-
dependent relaxation and coronary flow reserve, indicating
the progression in MetS severity.6,24-26 Given the decreased
expression of Notch and angiogenesis signaling proteins,
one would expect there would also be decreased vessel
density. In the present study, however, we did not find anyhosphate-biotin nick end labeling (TUNEL) staining in chronically ischemic
up;MetS, Ossabaw atherogenic diet (to induce metabolic syndrome) group;
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E
T
Evolving Technology/Basic Science Elmadhun et al
E
T
/B
Sdifference in arteriolar or capillary density in the MetS
group compared with the CTL group. This finding might
have been because these pigs had been supplemented with
a high-fat diet for a relatively short period and developed
early-stage MetS. Importantly, the molecular changes in
angiogenesis protein expression precede the histologic
changes and reductions in vessel count. If the pigs
were fed the high-fat diet for a longer period and had
longstanding chronic MetS, the molecular downregulation
of Notch and angiogenesis signaling would manifest in a
histologically visible reduction in angiogenesis. Trask and
colleagues24 reported decreased capillary density in
Ossabaw pigs that were older and had hadMetS for a longer
duration.
In addition to its pro-angiogenic properties, Notch
signaling has been found to modulate apoptosis and survival
signaling. In cell cultures, pro-apoptotic tumor necrosis
factor-a administration downregulated Notch4 activity.27
Notch4 also increased expression of Bcl2, thereby protect-
ing endothelial cells from lipopolysaccharide-triggered
apoptosis.28 Notch1 signaling in rat cardiomyocytes
reduced apoptosis in ischemic preconditioning by
upregulating Bcl2 and downregulating Bax.29 Thus, Notch
signaling could be used to promote endothelial generation
and angiogenesis and inhibit endothelial and cardiomyocyte
apoptosis. Studies in oncologic biology have shown that
Notch signaling inhibits apoptosis through the Akt pathway
in neoplastic tissues.30,31 In the present study, we examined
the effect of the MetS on apoptosis–survival signaling in
ischemic myocardium. A significant decrease was seen in
the pro-survival proteins phosphorylated P38 and heat
shock protein 90, a decrease in the inhibited form of
pro-apoptosis protein phosphorylated Fox03, and
upregulation of pro-apoptosis protein caspase 8 in the
MetS group. We also saw a trend toward increased
expression of the pro-apoptosis proteins apoptosis inducing
factor and cleaved caspase 3 in the MetS group. The
increase in pro-apoptosis protein expression and decrease
in the expression of survival proteins in the MetS group
was supported by TUNEL staining, which demonstrated
increased cell death in the MetS group compared with the
CTL group. These results suggest that MetS promotes
apoptosis signaling and increases cell death in the setting
of chronic myocardial ischemia. Although we have
previously reported that no difference was present in
cardiac function, long-term MetS-mediated cell death
might result in decreased contractility and reduced
adaptability to myocardial ischemia.8 Our finding of
decreased Notch signaling in this early-stage MetS model
is consistent with these molecular signals being causally
related to decreased angiogenesis in later stage MetS.24
The MetS poses a significant public health dilemma, and
its prevalence is increasing, with no signs of slowing.32
Notch signaling has been established as an integral1054 The Journal of Thoracic and Cardiovascular Surcomponent of angiogenesis and cell survival in the postnatal
heart. Elucidating this complex signaling network could
assist in identifying possible Notch targets and its
applicability and efficacy in human pathologic entities.
We have provided evidence that MetS inhibits Notch
signaling and promotes cell death in the chronically
ischemic myocardium, which could be one way that MetS
negatively affects overall cardiac health and increases the
risk of developing cardiovascular disease.
Study Limitations
The present study had several limitations in the
presentation and analysis. Although the swine in our study
had early MetS, the known vascular consequences of
MetS were not demonstrated in the chronically ischemic
myocardium (ie, no difference was seen in vessel count or
microvessel relaxation). In future studies, it would be
helpful to repeat the study with multiple harvest points to
establish a time course for the molecular and histologic
changes in angiogenesis in the setting of ischemia and early
and established MetS. Furthermore, although we found
differences in Notch expression in the present animal
model of early MetS and chronic ischemia, causality with
angiogenesis has not been clearly established. Future
studies with directed upregulation of Notch receptor or
ligands are warranted to further elucidate the relationship
among Notch signaling, MetS, and chronic myocardial
ischemia.
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Dr Marc Ruel (Ottawa, Ontario, Canada). I wish to
congratulate Dr Elmadhun and her team, in the laboratory ofThe Journal of Thoracic and CarDr Frank Sellke, for an excellent presentation and for providing
me with the report in advance for review.
The findings depicted this morning are important because they
continue to increase our mechanistic understanding of the
angiogenic processes in pathologic cardiovascular states, which
is critical if these therapies are going to hopefully one day work
in the patients for whom they are destined.
In the study, the deleterious effects brought on by the
experimental re-creation of MetS did not exceed the formidable
ability of pediatric swine to normalize myocardial perfusion in
response to ameroid constrictor insertion. However, the core of
the study is what happens ‘‘subclinically.’’ You found that a
number of angiogenic proteins are downregulated by MetS in
this model and that apoptosis is increased. Several of the changes
seemed to occur in the perivascular area of the blood vessels, likely
involving smooth muscle cells.
I have the following questions.
Despite no differences in microsphere myocardial perfusion, is
it possible that the pigs in the MetS group might have been
more ischemic? In other words, are there limitations to micro-
sphere-measured perfusion that would have been highlighted
with imaging or by measuring endothelial-dependent or
even endothelial-independent responses, considering that the
localization of the angiogenic downregulation changes seemed
to occur in the smooth muscle cells. Could new vessels in the
MetS group have been less mature, or leakier, because of
the changes in the smooth muscle cells? Were the left circumflex
territory data compared with a control, non-intervened left
anterior descending or right coronary artery territory?
Dr Elmadhun. Thank you very much, Dr Ruel. To address your
questions: we did perform right and left heart catheterizations at
harvest, and we sent those results to an interventional cardiologist
who was able to quantify the Thrombolysis In Myocardial
Infarction blush score and the Rentrop score. We did not find
any differences between the CTL group and the MetS group;
thus, we do not believe, given that data and the perfusion data,
that the MetS group was more ischemic.
In terms of themicrosphere data limitations, this is the reference
standard to determine perfusion. Other methods can be used to
examine myocardial perfusion.We have previously done magnetic
resonance imaging studies and microvessel reactivity analysis.
However, at our institution, we are unable to do magnetic
resonance imaging studies. However, we did perform microvessel
reactivity studies, and we found increased relaxation in the
MetS group. This finding might have been related to the ‘‘thrifty
genotype’’ of the Ossabaw miniswine, which has allowed them
to survive on Ossabaw Island in the harsh feast and famine
ecology.
Related to vessel leakiness and possible, immature vessels in the
MetS group, this is very likely. However, we only used 1 harvest
point. It would be interesting in future studies to see whether, as
these vessels matured, if any difference was found in the vessel
count at a later point or a difference was found in myocardial
perfusion at a later point. This is an early MetS model. Perhaps
if we had extended this study for 9 months or 1 year or had
performed our study in adult, sexually mature animals, we might
have seen even more differences.diovascular Surgery c Volume 148, Number 3 1055
